Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: Prevalence and risk factors

Acta Neurologica Scandinavica

Volumn 114, Issue 6, 2006, Pages 384-391

  Janghorbani, M ^a,b   Rezvanian, H ^b   Kachooei, A ^b   Ghorbani, A ^b   Chitsaz, A ^b   Izadi, F ^b   Amini, M ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Complications; Diabetes mellitus; Diabetic neuropathy; Epidemiology; Iran; Peripheral neuropathy; Prevalence; Risk factors

Indexed keywords

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; INSULIN TREATMENT; IRAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NERVE CONDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; PREDICTION; PREVALENCE; PROTEINURIA; RETINOPATHY; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

ADULT; AGE FACTORS; AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HUMANS; IRAN; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; PROTEINURIA; RISK FACTORS; TIME FACTORS;

EID: 33750608988     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00716.x     Document Type: Article

References (39)

1. EDMONDS ME, BLUNDELL MP, MORRIS ME, THOMAS EM, COTTON LT, WATKINS PJ. Improved survival of the diabetic foot: the role of a specialised foot clinic. Q J Med 1986;60:763-71.
2. PAISEY RB, ARREDONDO G, VILLALOBOS A, LOZANO O, GUEVARA L, KELLY S. Association of differing dietary metabolic and clinical risk factors with microvascular complications of diabetes: a prevalence study of 503 Mexican type II diabetic subjects. II. Diabetes Care 1984;7:428-33.
3. VEVES A, MANES C, MURRAY HJ, YOUNG MJ, BOULTON AJM. Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care 1993;16:1187-9.
4. YOUNG MJ, BOULTON AJM, MACLEOD AF, WILLIAMS DRR, SONSKEN PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36:150-4.
5. RATZMANN KP, RASCHKE M, GANDER I, SCHIMKE E. Prevalence of peripheral and autonomic neuropathy in newly diagnosed type II (non-insulin-dependent) diabetes. J Diabetes Complications 1991;5:1-5.
6. KNUIMAN MW, WELBORN TA, MCCANN VJ, STANTON KG, CONSTABLE IJ. Prevalence of diabetic complications in relation to risk factors. Diabetes 1986;35:1332-9.
7. LEHTINEN JM, UUSITUPA M, SIITONEN O, PYORALA K. Prevalence of neuropathy in newly diagnosed NIDDM and non-diabetic control subjects. Diabetes 1989;38:1307-13.
8. FRANKLIN GM, KAHN LB, BAXTER J, MARSHALL JA, HAMMAN RF. Sensory neuropathy in non-insulin-dependent diabetes mellitus: The San Luis Valley Diabetes Study. Am J Epidemiol 1990;131:633-43.
9. WALTERS DP, GATLING W, MULLEE MA, HILL RD. The prevalence of diabetic distal sensory neuropathy in an English community. Diabet Med 1992;9:349-53.
10. VERHOEVEN S, VAN BALLEGOOIE E, CASPARIE AF. Impact of late complications in type 2 diabetes in a Dutch population. Diabet Med 1991;8:435-8.
11. HARRIS MI, EASTMAN R, COWIE C. Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population. Diabetes Care 1993;16:1446-52.
12. DYCK PJ, KRATZ KM, KAMES JL et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993;43:817-24.
13. MELTON LJ III, DYCK PJ. Epidemiology. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad Al, Porte D Jr, eds. Diabetic neuropathy, Vol. 15. Philadelphia, PA: Saunders, 1987;27-35.
14. PALUMBO PJ, ELVEBACK LR, WHISNANT JP. Neurologic complications of diabetes mellitus: transient ischemic attack, stroke, and peripheral neuropathy. Adv Neurol 1978;19:593601.
15. PIRART J. Diabetes and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1978;1:168-88.
16. THOMAS PK, ELIASSON SG. Diabetic neuropathy. In: Dyck PJ, Thomas PK, Asbury A, Weingrad A, Porte D Jr, eds. Diabetic neuropathy. Philadelphia, PA: Saunders, 1987;1773-810.
17. RATE RG, KNOWLER WC, MORSE HG et al. Diabetes mellitus in Hopi and Navajo Indians: prevalence of microvascular complications. Diabetes 1983;32:894-9.
18. JANGHORBANI M, AMINI M, GHANBARI H, SAFAIEE H. Incidence of and risk factors for diabetic retinopathy in Isfahan, Iran. Ophthalmic Epidemiol 2003;10:81-95.
19. JANGHORBANI M, AMINI M. Cataract in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors. Ophthalmic Epidemiol 2004;11:347-58.
20. THE DCCT RESEARCH GROUP. Factors in the development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). Diabetes 1988;37:476-81.
21. WARD JD. Diabetic neuropathy. In: Williams R, Papoz L, Fuller JH, eds. Diabetes in Europe. London: John Libbey and Company Ltd/Editions INSERM, 1994;72-7.
22. KIMURA J. Electrodiagnosis in diseases of the nerve and muscle: principles and practice. Philadelphia, PA: Davis, 1989;103-38.
23. TESFAYE S, STEVENS LK, STEPHENSON JM et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996;39:1377-84.
24. PARTANEN J, NISKANEN L, LEHTINEN J, MERVAALA E, SIITONEN O, UUSITUPA M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995;13:89-94.
25. BORU UT, ALP R, SARGIN H et al. Prevalence of peripheral neuropathy in type 2 diabetic patients attending a diabetes center in Turkey. Endocr J 2004;51:563-7.
26. ROTA E, QUADRI R, FANTI E et al. Electrophysiological findings of peripheral neuropathy in newly diagnosed type II diabetes mellitus. J Peripher Nerv Syst 2005;10:348-53.
27. MASER RE, STEENKISTE AR, DORMAN JS et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1989;38:1456-61.
28. ELLENBERG M. Diabetic neuropathy: a consideration of factors in onset. Ann Intern Med 1960;52:1067-75.
29. WALKAMATSU H, ANAZAWA W, HIROSE H. Motor nerve conduction velocity in diabetes mellitus: relationship with arteriosclerosis, blood sugar, arterial blood pH, serum electrolytes and tissue temperature. Electromyography 1967;7:185-6.
30. TACKMANN W, KAESER HE, BERGER W, RUEGER AN. Sensory and motor parameters in leg nerves of diabetic inter-correlations and relationship to clinical symptom. Eur Neurol 1981;20:344-50.
31. HOMAN WH, HART ZH, FRANK RN. Correlate of delayed motor nerve conduction and retinopathy in juvenile onset diabetes mellitus. J Pediatr 1983;3:351-6.
32. ZIEGLER D, CICMIR I, WIEFELS K, BERGER H, GRIES FA. Peripheral and autonomic nerves function in long-term insulin-dependent diabetes. Diabetes Res 1987;4:9-14.
33. THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
34. UK PROSPECTIVE DIABETES STUDY (UKPDS) GROUP. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.
35. KLEIN R, KLEIN BE, MOSS SE. Relation of glycaemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med 1996;124:90-6.
36. UK PROSPECTIVE DIABETES STUDY (UKPDS) GROUP. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
37. FRANKLIN GM, SHETTERLY SM, COHEN JA, BAXTER J, HAMMAN RF. Risk factors for distal symmetry neuropathy in NIDDM: The San Luis Valley Diabetes Study. Diabetes Care 1994;17:1172-7.
38. MITCHELL BD, HAWTHORNE VM, VINIK AI. Cigarette smoking and neuropathy in diabetic patients. Diabetes Care 1990;13:434-7.
39. LEHTINEN JM, NISKANEN L, HYVONEN K, SIITONEN O, UUSITUPA M. Nerve function and its determinants in patients with newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus and in control subjects: a 5-year follow-up. Diabetologia 1993;36:68-72.